Objective-Low-density lipoprotein receptor-related protein 1 (LRP1) is a large endocytic and signaling receptor that is abundant in vascular smooth muscle cells. Mice in which the lrp1 gene is deleted in smooth muscle cells (smLRP1
T he low-density lipoprotein (LDL) receptor-related protein 1 (LRP1) is a large endocytic and signaling receptor that mediates the endocytosis of several ligands, including proteases and protease-inhibitor complexes.
1 LRP1 regulates a number of physiological processes, including tPA-induced disruption of the blood-brain barrier 2 and macrophage migration. 3, 4 Genome-wide association studies reveal that the LRP1 gene represents a susceptibility locus for elevated plasma lipids, 5 for abdominal aortic aneurysms, 6 and for coronary heart disease. 7 Mechanisms by which LRP1 modulates the development and progression of cardiovascular disease are currently unknown, but studies in vascular smooth muscle cells (SMCs) reveal that LRP1 can mediate the uptake of aggregated LDL, [8] [9] [10] which contributes to lipid loading in these cells. Genetic studies in mice demonstrate that the lrp1 gene expressed in vascular SMCs [11] [12] [13] and macrophages [14] [15] [16] protects the vessels from the development of atherosclerosis and restenosis, revealing that LRP1 is a key receptor that regulates the integrity of the vasculature during vessel wall remodeling. Mice deficient in SMC LRP1, when on an LDL receptor-deficient background, display excessive SMC proliferation, resulting in enlarged aortas, aneurysms formation, and increased susceptibility to cholesterol-induced atherosclerosis. This results from excess platelet derived growth factor (PDGF)-signaling in smooth muscle cell LRP1 (smLRP1) −/− mice, and total and phospho-platelet derived growth factor receptor (PDGFR)-β levels are significantly increased in the vessels of these mice. 11, 12 Mice deficient in SMC LRP1 not on an LDL receptor-deficient background have also been generated, and SMCs isolated from these mice display accelerated growth rates and are depleted of calponin, a marker for contractile SMC phenotype. 13 Interestingly, these mice display increased injury-induced neointimal hyperplasia.
Integral to the normal physiological function of the large elastic arteries is the extracellular matrix (ECM), especially collagen and elastin that are the major matrix components of these vessels. 17 Collagen provides strength and prevents failure of the vessels at high pressure, whereas elastin provides reversible extensibility during cyclic loading of the cardiac cycle. 17 Collagens turnover continually throughout life 18 and, as we age, collagen deposition increases, leading to stiffening of the vessels and contributing to the development of cardiovascular disease, including hypertension. 19 In contrast, elastin does not turnover in normal, healthy arteries 20 ; thus damage or degradation of elastin results in severe consequences, including aneurysms and aortic dissections.
Mechanisms associated with fragmentation and degradation of the elastic fibers in the vasculature are not fully understood, but it is clear that a major contributor to this process results from the accumulation of excess protease activity. Matrix metalloproteinase (MMP)2 in concert with MMP9 21 and membrane type I metalloproteinase (MT1)-MMP 22 have been identified to contribute to the development of aneurysms in mouse models. Interestingly, the levels of MMP2 and MMP9 are both regulated by LRP1. 23, 24 In the current investigation, we initiated studies to define mechanisms by which SMC LRP1 maintains the integrity of the vasculature. Our findings reveal that LRP1 protects the vasculature by regulating matrix deposition and protease activity in the vessel wall.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Effective Deletion of LRP1 From SMCs
To investigate the role of LRP1 expressed in vascular SMCs on the integrity of the vasculature, we generated smooth muscle lrp1 knockout mice by crossing sm22 promoter-driven cre transgenic mice with lrp1 flox/flox mice. Immunoblotting of extracts from the aorta revealed an effective deletion of the lrp1 gene ( Figure 1A ), whereas immunofluorescence studies on aortic SMCs isolated from wild-type (WT; Figure  1B 
Aortic Dilatation and Reduced Basal Blood Pressure in smLRP1 −/− Mice
We initially measured several physiological parameters to determine whether genetic deletion of lrp1 has an impact on aortic integrity. Echocardiographic measurements revealed substantial increases in the area of the aortic root ( Figure  1H ) as well as in the area of the ascending aorta ( Figure  1I ) in smLRP1 −/− mice (51% and 55% increase, respectively). Our study also revealed a significant decrease in the mean blood pressure in smLRP1 −/− mice, resulting from a decrease in both the systolic and diastolic blood pressure ( Figure 1J ).
Because the sm22 (taln) gene is transiently expressed in the heart during development 25 and because LRP1 is expressed in the heart with unknown function, we studied left ventricular geometry and function using biomicroscopy (high frequency ultrasound). We did not detect any difference in the dimensions or the wall thickness of the left ventricle (LV) either in systole or diastole between smLRP1 −/− and WT mice. This indicates normal LV geometry in smLRP1 −/− mice, and thus these mice have no geometric deficiencies such as myocardial hypertrophy or ventricular remodeling (Table I in (Table I in the online-only Data Supplement). The maximal mitral E wave velocity and the mitral E/A wave ratio were significantly greater in smLRP1 −/− mice, with no change in the mitral A wave velocity (Table I in the online-only Data Supplement). Additional work is required to determine why the mitral E wave velocity is increased in smLRP1 −/− mice. We conclude from all of the measurements that there is no defect in cardiac function as a consequence of transient deletion of the lrp1 gene in cardiac myocytes during development. Therefore, the main cause of hypotension observed in smLRP1 −/− mice is a result of decreased peripheral vascular resistance ( Figure  1K ), most likely because of impaired vessel contractions that were previously noted in studies using aortic rings from smLRP1 −/− mice.
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Deregulation of Connective Tissue Growth Factor and Increased Matrix Deposition in the Aortas of smLRP1 −/− Mice
To identify the potential mechanisms by which SMC LRP1 regulates the integrity of the vessel wall, we used quantitative proteomics to assist in the identification of key molecules that might contribute to the phenotype observed in smLRP1 −/− mice. In these experiments, we subjected 5-mm sections of the ascending aortas pooled from WT and smLRP1 −/− mice to the differential extraction protocol of Didangelos et al 26 after which the final extract, containing ECM proteins, was subjected to proteomics analysis. The results identified a number of proteins (Table III in the online-only Data Supplement), some of which were altered in smLRP1 −/− mice. Strikingly, the levels of several matrix proteins are altered in smLRP1 −/− aortas (Table) . These include various collagens, ECM proteoglycans, cell adhesion proteins, proteins involved in elastogenesis as well as a matrix-associated protease. The proteomics findings were confirmed by staining sections of aorta from both WT and smLRP1 −/− mice with Masson's Trichrome staining ( Figure I in the online-only Data Supplement), which revealed increased collagen staining in both the media and adventitia of vessels from smLRP1 −/− mice. These results are in agreement with previous work. 29 Consistent with increased matrix deposition in vessels of smLRP1 −/− mice, we also noted increased thickening of the media of the aorta in these mice. This was even apparent in newborn mice (Figure 2A) , and increased as the mice aged ( Figure 2B) . Examination of the proteomics data revealed a potential mechanism by which deletion of LRP1 in SMCs regulates matrix deposition because the levels of connective tissue growth factor (CTGF) were found to be significantly elevated in smLRP1 −/− mice ( Figure 2C ; Table) . CTGF is a key mediator of fibrosis 30 and is known to induce collagen synthesis in SMCs and fibroblasts. In addition, CTGF is an LRP1 ligand. 31 We also measured levels of CTGF mRNA in the aorta, which revealed no differences between WT and smLRP1 −/− mice ( Figure 2D ). As expected for normal vessels, immunohistochemical analysis of aortic tissue revealed very little expression CTGF in WT mice ( Figure 2E ), but interestingly, abundant expression of CTGF was detected in the media of smLRP1 −/− mice ( Figure 2F ). Together, these results reveal that genetic deletion of LRP1 in SMCs leads to excessive accumulation of CTGF, a known mediator of matrix production. Given the known role of CTGF in promoting matrix deposition, we hypothesize that the collagen deposition seen in smLRP1 −/− mice, as well as age-dependent medial thickening, results from excess accumulation of CTGF in the vessel wall.
Deregulated Protease Levels in Aortas of smLRP1 −/− Mice
Immunohistochemical analysis of aortas from smLRP1 −/− mice also revealed severe disorganization and degradation of the elastic lamina ( Figure 3B , arrow) consistent with reports from earlier studies. 11 With elastic Van Gieson staining, elastin fibers in smLRP1 −/− mice were characterized by random breaks and unusually thinner elastic fiber deposition both in medial and adventitial layers of aortic vessel wall ( Figure  3B , arrowhead). We also detected an unusual architecture of elastin fibers in smLRP1 −/− in comparison with WT, suggesting a change in the functional properties of these fibers. To gain insight into structural defects, we performed ultrastructural analysis of the vessels. As expected, vessels from WT mice displayed an aortic elastic lamina (*) structure that is highly organized ( Figure 3C ) and in close contact with a wellorganized medial ECM, which includes fibrillin and collagen fibers ( Figure 3E ). In addition, the elastic lamina is also in close contact with contractile SMCs (Figure 3E ), which establish cell-cell contact in the aortic wall of WT mice ( Figure  3G ). In contrast, the elastic lamina in smLRP1 −/− mice is disrupted and degraded ( Figure 3D ) and in loose contact with disarrayed and unorganized ECM molecules ( Figure 3F ). Furthermore, SMCs extend cytoplasmic processes through the disrupted elastic lamina ( Figure 3D ). Disruptions of the elastic lamina as well as the rest of medial ECM are associated with infiltration of macrophages (Mϕ) that are involved in clearing degradation products of ECM by large phagocytic vesicles ( Figure 3H ). Vascular SMCs in smLRP1 −/− mice have prominent synthetic organelles, including rough endoplasmic reticulum, ribosomes, and synthetic vesicles ( Figure 3H , bracket), which correlates with the significant thickening of aortic media and the increase in matrix molecules in these mice (Table I in the online-only Data Supplement).
Our quantitative proteomics data identified a key protease that is deregulated in the vessels of smLRP1 −/− mice ( Figure 4A ). This enzyme, high-temperature requirement factor A1 (HtrA1), is a secreted serine protease that degrades several matrix components including decorin, fibronectin, aggrecan, type II collagen 32, 33 and impairs elastogenesis by cleaving fibulin 5. 32 Interestingly, although HtrA1 protein levels were increased in smLRP1 −/− aortic extracts, mRNA levels for htra1 were not altered in these mice ( Figure 4B ). To confirm the proteomics results, we performed immunoblot analysis on extracts from the descending aorta of WT and smLRP1 −/− mice. The results ( Figure 4C and 4D) confirm increased expression of HtrA1 in aortic extracts from smLRP1 −/− mice. The fact that HtrA1 protein levels are significantly elevated in aortas from smLRP1 −/− mice, whereas mRNA levels of htra1 are unchanged, raises questions about how the protein levels of HtrA1 might be regulated. One mechanism we considered is the possibility that HtrA1 might be an LRP1 ligand, and if so, removal of the protease by LRP1-mediated endocytosis might represent a viable mechanism by which LRP1 regulates HtrA1 levels. To test this proposal, we used surface plasmon resonance experiments to determine whether HtrA1 binds to LRP1. The results revealed a concentration-dependent have all been reported to recruit macrophages into the vessel wall. Because we detected macrophages in the vessel wall of smLRP1 −/− mice in ultrastructural studies, we stained sections of the descending aorta to determine the magnitude of macrophage infiltration using anti-Mac2 IgG. The results revealed substantial recruitment of macrophages in the media of aortas from smLRP1 −/− mice ( Figure 5B ). As expected, we were unable to detect any Mac2-positive staining in sections from WT mice.
Because macrophages are a source of protease activity, we quantified the levels of several proteases known to be expressed by macrophages in the aortas of WT and smLRP1 −/− mice. By using an ELISA specific for murine urokinase-type plasminogen activator, we found a trend toward increased expression of urokinase-type plasminogen activator in smLRP1 −/− mice ( Figure 5C ), but the data did not quite reach significance (P=0.07; n=5). MT1-MMP (MMP14) levels were quantified by immunoblot analysis, and the results reveal a significant increase in MT1-MMP antigen levels in the aorta of smLRP1 −/− mice ( Figure 5D ). To measure gene expression levels of these and other proteases in the vessel wall, we used quantitative RT-PCR arrays to identify changes in mRNA levels of proteases and other matrix genes (Table II in the online-only Data Supplement). These results revealed that although there seemed to be an increase in the mRNA levels of MT1-MMP ( Figure 5E ), the results did not reach significance (P=0.305; n=3).
MMP2 and MMP9 are the gelatinases produced by macrophages, and thus we measured the levels of these MMPs in the aortas of WT and smLRP1 −/− mice by using gelatin zymography. These studies demonstrated increased activities of MMP9, MMP2, and active forms of MMP2 ( Figure 5F ). By using purified MMP2 and MMP9 as standards in this assay, we quantified the levels of these metalloproteinases, which indicated increased levels of MMP9 ( Figure 5G ), pro-MMP2 ( Figure 5I ), and active MMP2 ( Figure 5J ) in the aortas of smLRP1 −/− mice when compared with WT mice. Interestingly, mRNA levels of mmp9 in the aorta were not increased in smLRP1 −/− mice ( Figure 5H ). In contrast, mRNA levels of mmp2 in the vessel wall of smLRP1 −/− mice appear elevated with a trend toward significance (P=0.08; Figure 5K ). In summary, deletion of the lrp1 gene in SMCs is associated with increased inflammation in the vessel wall, which we hypothesize results in increased protease activity and levels leading to increased elastic lamina degradation.
Increased Extracellular Signal-regulated Kinase Activation in Aortas From smLRP1 −/− Mice
Previous studies examining smLRP1 −/− mice in an atherosclerotic model (LDLr −/− ; Western diet) observed overexpression of the PDGFRβ 11 and abnormal activation of the PDGF 11 and transforming growth factor β (TGFβ) 12 -signaling pathways. Activation of the PDGFRβ was also reported in smLRP1 −/− mice not on an LDLr −/− background, although the magnitude of the effect was minimal. 13 We examined smLRP1 −/− mice for evidence that the PDGF-and TGFβ signaling pathways were abnormally activated. The results of these studies are shown in Figure 6 and demonstrate that total PDGFRβ levels in smLRP1 −/− mice are identical with those in WT mice ( Figure 6A and 6B). In contrast, we noted slightly elevated levels of phospho-extracellular signal-regulated kinase 42/44 ( Figure 6C and 6D), suggesting activation of the PDGF pathway. However, we were unable to confirm that phosphorylated forms of PDGFRβ were elevated in smLRP1 −/− mice, as immunoblot analysis revealed very low levels of phospho-PDGFRβ with no significant difference between WT and smLRP1 −/− mice. Finally, levels of phospho-SMAD2/3, which were also low, appeared similar between WT and smLRP1 −/− mice (data not shown).
Discussion
Previous studies 11, 12 revealed that deletion of the lrp1 gene in SMCs significantly enhances the development of atherosclerosis in mice when on an LDL receptor-deficient background and fed a Western diet. This was attributed to deregulation of the PDGF-signaling pathway and was confirmed by demonstrating that the total PDGFR-β and phospho-PDGFR-β levels were significantly increased in the vessel wall of these mice. In addition to the rapid development of atherosclerosis, smLRP1 −/− and LDL receptor-deficient mice also demonstrated elastic lamina degradation and aneurysm formation. SMC LRP1-deficient mice also display a degraded elastic lamina, even when not on an LDL receptor-deficient background. 13, 29 However, it is not clear that deregulation of the PDGF-signaling pathway contributes to the phenotype observed in these mice because the changes in PDGFR and phospho-PDGFR levels in the aorta are rather modest. 13, 29 Furthermore, our studies using smLRP1 −/− mice failed to detect any changes in PDGFR-β or phosho-PDGFR-β levels in the aorta, indicating that the aortic dilatation, elastic lamina fragmentation, and matrix deposition that we report in the current study results from mechanisms distinct from excess PDGF-mediated signaling. The objectives of the current study were to define mechanisms by which LRP1 modulates these processes.
We noted significant aortic dilatation in smLRP1 −/− mice, which we attribute to degradation and disorganization of the elastic lamina. Degradation of the vessel wall ECM likely results from deregulation of protease activity in smLRP1 −/− mice, and proteomics analysis discovered excessive levels of HtrA1 in smLRP1 −/− mice that was validated by immunoblot analysis of aortic extracts. HtrA1 is a secreted serine protease that is ubiquitously expressed and is especially abundant in vascular SMCs. 37 In vitro studies reveal that HtrA1 can degrade several matrix proteins, including fibronectin, type II collagen, decorin, aggrecan, and fibulin 5.
32,33 A single-nucleotide polymorphism in the HtrA1 promoter region resulting in increased HtrA1 transcript levels has been associated with the progression of age-related macular degeneration, 38 ,39 suggesting a role for HtrA1 in matrix degradation. A direct in vivo role for HtrA1 in fragmentation of the elastic layer is revealed from studies in which HtrA1 was overexpressed in the pigment epithelial layer of the retina in transgenic mice. HtrA1 overexpression resulted in a fragmented and less continuous elastic layer of Bruch's membrane, 32 much like the results obtained in the present study. Thus, the studies of Vierkotten et al 32 confirm a role for HtrA1 in fragmentation and disorganization of the elastic layer.
In addition to its ability to degrade matrix, HtrA1 also regulates the TGFβ signaling pathway. This was discovered when mutations in the HTRA1 gene were associated with familial ischemic cerebral small-vessel disease (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy [CARASIL] ) 40 that results from deregulation of TGFβ signaling. The mechanism by which HtrA1 regulates TGFβ signaling has been identified in studies by Shiga et al, 41 who demonstrated that HtrA1 mediates the proteolysis of the prodomain of proTGF-β1 within the endoplasmic reticulum. Cleaved proTGF-β1 is then degraded by ER-associated degradation. 41 Consequently, the impact of HtrA1 expression is to reduce the amount of mature TGF-β1 secreted by cells.
Our findings that LRP1 regulates levels of HtrA1 in the vessel wall identify a new function for LRP1 in maintaining vessel wall integrity. Interestingly, although protein levels of HtrA1 were increased in the vessel wall of smLRP1 −/− mice, mRNA levels were unaltered, suggesting that the regulation of HtrA1 by LRP1 does not occur at the transcription level. Indeed, we found that purified LRP1 binds HtrA1 with high affinity and that LRP1-expressing cells internalize HtrA1 in a receptor associated protein-sensitive manner. These studies identify HtrA1 as a novel LRP1 ligand and further reveal that LRP1 can regulate HtrA1 levels by binding and mediating the rapid endocytosis of this protease. In addition to HtrA1, we noted excess MMP9, MMP2, and MT1-MMP in the vessel wall of smLRP1 −/− mice, all of which contribute to degradation of elastic fibers and the development of aneurysms in mouse models. 21, 22 Both MMP9 23 and MMP2 24 levels are regulated by LRP1; MMP9 directly binds to LRP1, whereas MMP2 binds to thrombospondin-2, which in turn binds to LRP1.
Proteomic analysis also revealed excess matrix deposition in the vessel wall of smLRP1 −/− mice. Consistent with this, we noted medial thickening in these mice, which became more severe as the mice age. Increased collagen deposition causes stiffening of the vessels, which normally results in hypertension. However, smLRP1 −/− mice are hypotensive, which likely results from impaired vasoconstriction in vessels of smLRP1 −/− mice because Basford et al 13 found impaired contractility in aortic rings from smLRP1 −/− mice. We attribute excess matrix deposition to our discovery of significant elevation of CTGF in vessels of smLRP1 −/− mice. CTGF is a member of the CCN family of secreted matricellular proteins 42 that is a key mediator of fibrosis 30 and plays an important role in vascular development. CTGF is expressed in endothelial cells as well as SMCs in the developing vasculature, and CTGF-deficient mice exhibit vascular defects beginning at day E14.5. In the larger vessels, minor enlargement of the vessels and disorganization of the tunica media in CTGFdeficient mice was noted. In the aortic media of CTGF null mice, SMCs exhibited a different morphology from WT mice and were not organized into distinct layers, 43 suggesting that CTGF modulates SMC physiology.
The molecular mechanisms by which CTGF elicits cellular responses are not clear, but CTGF may perform some of these functions by modulating the TGFβ signaling pathway because CTGF synergizes with TGFβ to induce matrix deposition. Abreu et al 44 demonstrated that CTGF directly binds bone morphogenetic protein-4 and TGFβ1 and modulates their signaling properties by inhibiting bone morphogenetic protein-4-mediated signaling and enhancing TGFβ1-mediated signaling. CTGF is a ligand for LRP1, 31 which mediates the rapid endocytosis of this molecule. The present data reveal a critical role for LRP1 in regulating levels of CTGF in the vasculature and, in the absence of SMC LRP1, CTGF levels accumulate. Because mRNA levels of ctgf, like htra1, were not changed in smLRP1 −/− mice, the data are consistent with an important role for LRP1 in the clearance of CTGF.
The relationship between disorganized elastic lamina, collagen accumulation in the media of the vessel wall, and hypotension is interesting and not predicted because excess collagen deposition is normally associated with hypertension. We hypothesize that genetic deletion of LRP1 from SMCs alters their normal physiology in the vessel wall, which in turn impacts their contractile properties as well as their regulation of ECM deposition. This is supported by ultrastructural studies revealing that SMCs in the vessel wall of smLRP1 −/− mice have prominent synthetic organelles revealing a synthetic state. SMCs are highly specialized cells that express a unique assortment of contractile proteins 45 and function to regulate vascular tone and diameter. During development, SMCs are responsible for the deposition of matrix proteins and for the correct assembly of elastic fibers, the largest and most complex structures of the ECM. 46 Ultrastructural studies in smLRP1 −/− mice reveal a disorganized matrix. We further propose that accumulation of excess HtrA1 in smLRP1 −/− vessels results in a disruption of normal elastic fiber and ECM formation that occurs during vessel development as well as during postnatal and adult life. The accumulation of ECM degradation products throughout adult life has the potential to recruit macrophages, [34] [35] [36] which are detected in the vessel wall of smLRP1 −/− mice. These inflammatory cells are a source of additional proteases capable of degrading the elastic fibers.
In summary, we have discovered pathways in the vessel wall in which LRP1 regulates fibrosis by controlling CTGF levels and vascular structural integrity by modulating HtrA1 levels. Our findings suggest a critical role for LRP1 in maintaining an intact elastic lamina and appropriate vessel function by reducing protease activity and collagen deposition. Understanding mechanisms by which LRP1 protects the vasculature and regulates SMC physiology will give important insight into mechanisms regulating vessel wall homeostasis and pathology. Furthermore, our studies highlight 2 new molecules (CTGF and HtrA1) that seem to play critical roles in We discovered that deletion of the low-density lipoprotein receptor-related protein 1 in smooth muscle cells leads to extensive aortic dilatation resulting from a disorganized and degraded elastic lamina in our knockout mice. This is a serious problem because it leads to aneurysms.
In addition, we noted medial thickening of the arterial vessels, resulting from excess matrix deposition. Quantitative differential proteomic analysis of vessels from wild-type and knockout mice revealed accumulation high-temperature requirement factor A1 in knockout mice. High-temperature requirement factor A1 is a secreted protease that is known to degrade matrix components and to impair elastogenesis. Proteomics analysis also identified accumulation of connective tissue growth factor in knockout mice. Connective tissue growth factor is a known low-density lipoprotein receptor-related protein 1 ligand and a key mediator of fibrosis. Our studies highlight 2 new molecules (connective tissue growth factor and high-temperature requirement factor A1) that contribute to detrimental changes in the vasculature and, therefore, represent new target molecules for potential therapeutic intervention. Surface plasmon resonance. SPR measurements were carried out as described 6 . Full length LRP1 was immobilized onto a CM5 sensor chip surface at 5.8 fmol/mm 2 (3,500 RU) density.
MATERIAL AND METHODS
Animals
Data were analyzed by fitting to a pseudo-first order process from which Req was determined.
Req derived from this analysis was replotted versus HtrA1 (Origene) concentrations (6, 12, 15, 50, 100 and 200 nM) and the data were fit to a single class of sites by nonlinear regression analysis using SigmaPlot 11 software.
Electron microscopy. Descending aortas were fixed by cardiac perfusion with PBS, fixed in 3% glutaraldehyde in 0.1 M sodium cacodylate (pH 7.4), and sequentially stained with osmium tetroxide, tannic acid, and uranyl acetate as described 7 . After dehydration through a graded series of methanol and infiltration with Epon, tissues were embedded in pure Epon and polymerized. Sixty-nm sections were counterstained with uranyl acetate and lead citrate and viewed using a FE Tecnai 12 transmission electron microscope. Two aortas were imaged for each genotype, and several grids were examined for each aorta.
SMC Isolation. SMC were isolated using established protocols 8 . Cells were cultured in DMEM (Cellgro), 10% FBS (Bench Mark), 1% penicillin/streptomycin/glutamine (Hyclone).
Immunofluorescence microscopy was performed as described 9 . Polyclonal anti-LRP1 antibody 6 and -SMA (Clone 1A4, Sigma-Aldrich, St Louis, MO), were used for double labeling.
Quantitative real-time reverse transcriptase (RT)-PCR.
Total RNA from descending aortas were isolated using Trizol (Invitrogen) reagent as directed by the manufacturer. For each experiment, total RNA from 2 mice were pooled, and cDNA preparation and qRT-PCR using the Extracellular Matrix and Adhesion molecule array from SA Biosciences were performed as described 6 . The experiments were repeated 3 times. A complete list of genes analyzed is reported in Supplemental Table II . actb, hprt1 and gapdh were used as housekeeping genes.
Gelatin zymography. Descending aortas with the adventitia removed were homogenized in T-
Per tissue extraction buffer (Thermo Scientific). MMP-2 and MMP-9 in the homogenate were quantified by gelatin zymography following concentration on Gelatin-Sepharose TM 4B bead (20 l). After overnight incubation with the beads at 4°C, MMPs were eluted with 3x non-reducing sample buffer. Samples were run on Novex® 10 % Zymogram gel (Life Technologies), and the gel was then renatured and developed according to the manufacturer's protocol. The gel was stained with Coomassie blue (0.1% Coomassie R250 in 10% acetic acid 40% ethanol) for 30 min, and destained for 3 hrs, prior to analysis using. Purified MMP2 and MMP9 were used to establish standard curves. Densitometry was performed on scanned zymograms using ImageJ (National Institutes of Health, Bethesda, MD, USA)
Immunoblotting and ELISA.
Descending aortas with the adventitia removed were homogenized in solubilization buffer as described 6 . Equal amounts of homogenates were separated on a 4-12% SDS-polyacrylamide gel and electrophoretically transferred to nitrocellulose membranes. Immunoblotting was performed as described 6 . The following primary antibodies were used; PDGFR , / Tubulin, Phospho p44/42 MAPK (Thr202/Tyr 204,) (Cell Signaling), and MT1-MMP (Novus Biologicals), polyclonal LRP1 antibody (Rab2629), and HtrA1 (N-term) (Sigma). To quantify uPA levels in extracts, the mouse uPA ELISA kit from Molecular Innovation was employed.
Echocardiography and blood pressure measurements. These measurements were performed as described 10 and the data analysis were performed blinded as to experimental groups. The
Vevo 2100 system with a 40 MHz scanhead (VisualSonics, Toronto, Canada) was used for 2D- Global quantification of protein expression. For each experiment, 5mm sections of aortas from 3-5 WT and smLRP1-/-mice were pooled and subjected to differential extraction as described 1 . The final extract containing extracellular matrix proteins was processed for proteomics analysis using the filter aided sample prep (FASP) method 2 . The peptides were then chemically labeled by reductive alkylation with either acetone (WT) or deuterated d6-acetone (smLRP1-/-). After combining the samples from WT and smLRP1-/-mice, they were fractionated as described 3 , and each fraction analyzed by rpLC-MS/MS using a 2hr separation gradient. The raw data was converted to mzXML format. Database searching, statistical validation of peptide and protein assignments and finally quantitation using ASAPRatio 4 were performed using the Trans-Proteomic Pipeline (TPP) software 5 . This experiment was repeated 3 times. Surface plasmon resonance. SPR measurements were carried out as described 6 . Full length LRP1 was immobilized onto a CM5 sensor chip surface at 5.8 fmol/mm 2 (3,500 RU) density. Data were analyzed by fitting to a pseudo-first order process from which Req was determined. Req derived from this analysis was replotted versus HtrA1 (Origene) concentrations (6, 12, 15, 50, 100 and 200 nM) and the data were fit to a single class of sites by nonlinear regression analysis using SigmaPlot 11 software.
SMC Isolation. SMC were isolated using established protocols 8 . Cells were cultured in DMEM (Cellgro), 10% FBS (Bench Mark), 1% penicillin/streptomycin/glutamine (Hyclone). Immunofluorescence microscopy was performed as described 9 . Polyclonal anti-LRP1 antibody 6 and -SMA (Clone 1A4, Sigma-Aldrich, St Louis, MO), were used for double labeling.
Quantitative real-time reverse transcriptase (RT)-PCR.
Total RNA from descending aortas were isolated using Trizol (Invitrogen) reagent as directed by the manufacturer.
For each experiment, total RNA from 2 mice were pooled, and cDNA preparation and qRT-PCR using the Extracellular Matrix and Adhesion molecule array from SA Biosciences were performed as described 6 . The experiments were repeated 3 times. A complete list of genes analyzed is reported in Supplemental Table II . actb, hprt1 and gapdh were used as housekeeping genes. Coomassie R250 in 10% acetic acid 40% ethanol) for 30 min, and destained for 3 hrs, prior to analysis using. Purified MMP2 and MMP9 were used to establish standard curves.
Densitometry was performed on scanned zymograms using ImageJ (National Institutes of Health, Bethesda, MD, USA)
Immunoblotting and ELISA. Descending aortas with the adventitia removed were homogenized in solubilization buffer as described 6 . Equal amounts of homogenates were separated on a 4-12% SDS-polyacrylamide gel and electrophoretically transferred to nitrocellulose membranes. Immunoblotting was performed as described 6 . The following primary antibodies were used; PDGFR , / Tubulin, Phospho p44/42 MAPK (Thr202/Tyr 204,) (Cell Signaling), and MT1-MMP (Novus Biologicals), polyclonal LRP1
antibody (Rab2629), and HtrA1 (N-term) (Sigma). To quantify uPA levels in extracts, the mouse uPA ELISA kit from Molecular Innovation was employed.
Echocardiography and blood pressure measurements. These measurements were performed as described 10 and the data analysis were performed blinded as to experimental groups. The Vevo 2100 system with a 40 MHz scanhead (VisualSonics, Toronto, Canada) was used for 2D-guided M-mode imaging of the left ventricle (LV) or the aorta in parasternal short-axis view at level of the papillary muscle or in the parasternal long-axis view, respectively. Pulse-wave Doppler imaging of the mitral inflow or the ascending aortic flow were obtained in the apical 4-chamber view or the suprasternal notch view, respectively. Mean aortic cross sectional area was calculated using mean aortic root diameter defined as (1/3 systolic diameter + 2/3 diastolic diameter). All the data include at least three beats from each projection. Blood pressure was measured by cannulation of 1 Fr high-fidelity pressure transducer (SPR-1000, Millar Instruments) into 6 the right carotid artery. The catheter tip was positioned to the aortic arch and data were calculated from 10-min stable waveforms following 30 min stabilization from surgery.
Endocytosis experiments. The iodination of HtrA1 and cell uptake experiments of 125 Ilabeled HtrA1 were performed in mouse embryonic fibroblasts and PEA-13 (LRP1 deficient cells) available from ATCC as described 11 .
Statistical Analysis. Data are presented as means ± SE and are analyzed for significance using Student's t-test, with p ≤ 0.05 set as the threshold for significance. All values represent at least 3 independent trials. The proteomics and qRT-PCR array data were compared using the Student's t-test. The p values obtained from this analysis were analyzed for false discovery rate (FDR) using the approaches described by Benjamini and Hochberg 12,13 . 
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